Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Sigma-Tau Names CEO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Sigma-Tau Names CEO

Lemus takes on newly created position

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dave Lemus has been promoted to the newly created position of chief executive officer of Sigma-Tau Pharmaceuticals. Mr. Lemus has served as chief operating officer since March 2012, and joined the company as vice president of finance in July 2011.
 
Prior to joining the company, Mr. Lemus was executive vice president and chief financial officer of MorphoSys AG, where he launched Germany’s first biotech IPO in 1999. Before MorphoSys, Mr. Lemus held a variety of senior management positions at Hoffmann-La Roche and Lindt Chocolate, in Switzerland. Mr. Lemus presently serves as board chairman of Proteros Gmbh in Munich, and as a non-executive board member of Axela Inc. in Toronto.
 
Professor Trevor M. Jones CBE, president of Sigma Tau USA Inc., said, “We are delighted to appoint Dave to this new position. His appointment comes at a pivotal time in the development of the company, as it now expands via commercialization of its proprietary internal R&D pipeline, and the pursuit of externally driven growth opportunities. The appointment of the chief executive role reflects the commitment Sigma Tau USA Inc. has to the field of rare diseases, and to the significant impact we expect these medicines will ultimately have on their respective physician and patient communities, alike.”
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters